tiprankstipranks
Guardant Health sees FY22 revenue $447M-$450M, consensus $445.24M
The Fly

Guardant Health sees FY22 revenue $447M-$450M, consensus $445.24M

For the twelve-month period ended December 31, as compared to the same period of 2021: Revenue of between $447M and $450M, an increase of 20%: Reported 124,800 tests to clinical customers and 26,000 tests to biopharma customers, an increase of 42% and 40%, respectively

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on GH:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles